Irinotecan Hydrochloride 68083-0382-01

Package NDC

68083-0382-01

Manufacturer: Gland Pharma Limited
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 18, 2019
Listing Expires: December 31, 2026
Application: ANDA212993

Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Irinotecan Hydrochloride	20 mg/mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

68083-0382-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (68083-382-01) / 5 mL in 1 VIAL, SINGLE-DOSE